Potassium Iodide for Preoperative Thyroidectomy
Yes, potassium iodide should be given in the immediate preoperative period for patients with Graves' disease undergoing thyroidectomy, typically for 10 days before surgery. 1
Primary Recommendation for Graves' Disease
The American Thyroid Association and American Association of Clinical Endocrinologists provide clear guidance on this matter:
- Patients with Graves' disease undergoing thyroidectomy should be rendered euthyroid with methimazole first, then potassium iodide should be given in the immediate preoperative period 1
- In exceptional circumstances (urgent surgery, inability to achieve euthyroid status, or antithyroid drug allergy), patients should receive beta-blockade plus potassium iodide preoperatively 1
Dosing Protocol
The technical specifications are straightforward 1:
- Lugol's solution: 5-7 drops (0.25-0.35 mL) three times daily, providing 8 mg iodide per drop
- SSKI (saturated solution): 1-2 drops (0.05-0.1 mL) three times daily, providing 50 mg iodide per drop
- Duration: Mix in water or juice for 10 days before surgery
- Alternative: Potassium iodide 65 mg tablets at 130 mg daily can achieve euthyroidism within 24 hours in selected cases 2
Mechanism and Benefits
Potassium iodide works by:
- Decreasing thyroid blood flow and vascularity 1
- Reducing intraoperative blood loss 3, 4
- Preventing thyroid storm from surgical stress 1
Recent evidence shows mixed results on clinical outcomes: While a 2026 meta-analysis found no significant differences in blood loss, operative time, or complications between iodine and control groups 5, a 2018 prospective study demonstrated that potassium iodide reduced transient hypoparathyroidism (7% vs 26%) and transient hoarseness (0% vs 16%) 4.
Important Caveats and Nuances
The European perspective differs: A 2018 French guideline states there are no indications for preoperative Lugol's iodine to reduce complications rates, leaving its use to the surgeon's discretion 6. This reflects that complication reduction correlates primarily with surgeon experience rather than iodine use.
The evidence is not as strong as the guideline recommendation suggests: Multiple recent studies 5, 7, 3 show that while potassium iodide decreases vascularity and blood loss, it does not consistently translate to clinically meaningful differences in operative time or major complications. One study even found longer operative times with potassium iodide use 7.
Clinical Algorithm
For Graves' disease patients scheduled for thyroidectomy:
- First priority: Render patient euthyroid with methimazole over 12-18 months if possible 1
- Add potassium iodide: Start 10 days before surgery using dosing above 1
- If urgent surgery or methimazole contraindicated: Use beta-blockade PLUS potassium iodide 1
- Stop antithyroid drugs at time of surgery 1
For non-Graves' thyroidectomy (toxic multinodular goiter, toxic adenoma, non-toxic goiter): The guidelines do not recommend routine potassium iodide use. It is specifically indicated for Graves' disease due to the unique pathophysiology and risk of thyroid storm.
Contraindications
Avoid potassium iodide in patients with 8:
- Iodine allergy
- Dermatitis herpetiformis
- Hypocomplementemic vasculitis
- Nodular thyroid disease with heart disease
Bottom Line
Despite evolving evidence questioning its impact on surgical complications, potassium iodide remains guideline-recommended for Graves' disease thyroidectomy based on its physiologic effects on thyroid vascularity and historical prevention of thyroid storm. The primary value may be in rapidly achieving euthyroidism preoperatively rather than reducing surgical difficulty. Given the low risk and potential benefits, particularly in preventing transient complications, it should be used as recommended by major endocrine societies 1.